Other Assets, Noncurrent in USD of Royalty Pharma plc from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Royalty Pharma plc quarterly Other Assets, Noncurrent history and change rate from Q4 2019 to Q3 2025.
  • Royalty Pharma plc Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $86,585,000, a 102% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Royalty Pharma plc Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $86,585,000 +$43,796,000 +102% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $85,491,000 +$57,936,000 +210% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $36,707,000 +$32,219,000 +718% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $33,534,000 +$27,012,000 +414% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $42,789,000 +$22,577,000 +112% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $27,555,000 -$1,853,000 -6.3% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $4,488,000 -$23,542,000 -84% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,522,000 -$23,107,000 -78% 31 Dec 2023 10-K 12 Feb 2025 2024 FY
Q3 2023 $20,212,000 -$10,401,000 -34% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $29,408,000 -$4,004,000 -12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $28,030,000 +$24,160,000 +624% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $29,629,000 +$25,484,000 +615% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $30,613,000 +$26,098,000 +578% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $33,412,000 +$27,452,000 +461% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $3,870,000 -$386,000 -9.1% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $4,145,000 -$5,852,000 -59% 31 Dec 2021 10-K 15 Feb 2023 2022 FY
Q3 2021 $4,515,000 -$376,000 -7.7% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $5,960,000 +$5,960,000 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 $4,256,000 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 $9,997,000 -$35,638,000 -78% 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q3 2020 $4,891,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $0 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q4 2019 $45,635,000 31 Dec 2019 10-K 24 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.